Quetmolimab: A Deep Dive into KANAb 001 and E-6011 The molecule, E-6011, is a new approach aimed at PD-1. Initial clinical data from the two studies, KANAb 001 and E-6011, reveal significant response in multiple malignancy kinds. In particular, findings highlight a likely advantage in p